Clinical Trial Update: rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular Goiter [Phase 2]

View source ↗

Summary

Phase 2 trial evaluates rhTSH with radioactive iodine therapy to improve iodine uptake and reduce goiter size in patients with benign non-toxic nodular goiter.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nodular Goiter

Drugs mentioned

• Iodine-131 (Iodine-131)
• Thyrogen (thyrotropin alfa)

Snippet

Sponsor: Steen Bonnema | Conditions: Nodular Goiter | Phase 2 | Status: COMPLETED